Card Tech Minutes 2013.01.09

Attendees

• Alan Katz - ACC
• Antje Schroeder - Siemens
• Barry Brown - Mortara
• Chris Melo - Philips
• Paul Dow - ACC
• Paul Seifert - Agfa
• Paul Varghese - Agfa
• Tom Dolan - Philips

Meeting Notes

• ACC provides two different methods of Surveys:
  • General survey for MDs (6-8 Q) asking broad questions about challenges faced by clinicians and how IHE can improve care delivery. (no cost to IHE, will take 1-2 weeks to execute, March earliest time frame)
  • Deeper dive (15-20 Q) w/ hospital execs to show the value of IHE solutions to their larger organizations. (cost will vary depending on target demographic, survey tool [on-line vs. phone] will take 6-8 weeks to execute, March or April earliest time frame)
• The decision was to start with the general survey and create the more detailed one based on the results of the general survey
• Draft questionaire, that was shared with Planning Committee prior to review with ACC Survey group

1. How important is multiple-vendor Interoperability to you in cardiology workflow
   1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
   2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
   3. medium - it always there and considered
   4. low – it never really comes up
2. What are key interoperability pain points that you experience today - please specify
3. What is your role in Cardiology IT purchasing decisions
   1. Decision maker, member of decision making unit
   2. Decision influencer – consulted by decision makers
   3. None
4. How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions
   1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
   2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
   3. medium - it always there and considered
   4. low – it never really comes up
5. Are you aware of IHE (Integrating the Healthcare Enterprise)
   1. ? never heard of it
   2. Somewhat familiar
   3. Very familiar – continually use it in my discussion on cardiology Interoperability
6. If yes - describe its role in addressing your interoperability concerns
   1. Very Valuable – please mention specific profiles used
   2. Not Available – vendors do not have requested profiles or only incomplete support
      1. Please illustrate
   3. Not fully applicable - it has gaps which doesn’t address my key concerns – please specify
7. Would you like a follow-up to find out more information?
   1. Contact method ( phone/email)
   2. no